Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Artz, MD, MS
City of Hope Medical Center
Principal Investigator - Mohamed Sorror, MD, MSc
Fred Hutchinson Cancer Center
Principal Investigator - Wael Saber, MD, MS
Medical College of Wisconsin/CIBMTR
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona and Phoenix Children'S Hospital
Phoenix, Arizona, United States
- City of Hope National Medical Center
Duarte, California, United States
- University of California San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- University of Florida
Gainesville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Memorial Cancer Institute
Pembroke Pines, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northside Hospital
Atlanta, Georgia, United States
- University of Chicago Medicine
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Indiana Blood and Marrow Transplantation
Beech Grove, Indiana, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Kansas, Blood and Marrow Transplant Program
Kansas City, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Umass Memorial Medical Center
Worcester, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Hospital Bone Marrow Transplant Program
Detroit, Michigan, United States
- Karmanos Cancer Center
Detroit, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Nebraska Medicine
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- New York Presbyterian Hospital/columbia University Medical Center
New York, New York, United States
- Unc Chapel Hill
Chapel Hill, North Carolina, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Siedman Cancer Center
Cleveland, Ohio, United States
- the Ohio State Universtiy
Columbus, Ohio, United States
- Hca Health Services of Oklahoma, Inc., University of Ok
Oklahoma City, Oklahoma, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jul 2019
- Primary completion
- 29 May 2023
- Completion
- 30 May 2023
- Last update posted
- 6 Feb 2024
- Registered enrollment
- 1,229
- Registry id
- NCT03992352
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.